Articles by Keyword for

Drugs developed to treat Alzheimer's disease produce only fleeting memory improvements and do not slow the overall course of the disease. Acetylcholinesterase inhibitors such as Aricept, Razadyne, and Exelon and NMDA receptor inhibitors such as Namenda have very limited value. There is a new experimental drug called J147 that at least in mice enhances...

  MIT studies have shown that a combination of choline, uridine, and DHA can improve memory in patients with early Alzheimer's disease by stimulating the growth of new synapses. About 40% of patients who consumed this cocktail improved on a test of verbal memory. It does not work on moderate or severe cases. There are several other approaches...

Parkinson's disease is not cured by any treatments we have today. Treatment is centered on blocking the symptoms of this chronic disease. There is a failure of energy production in vital areas of the brain that make dopamine. The energy producing part of the cell, the mitochondria, don't make enough energy to make dopamine and Parkinson's disease...